Diseases in Children with Atopic Dermatitis: Retrospective Cross-Sectional Study
https://doi.org/10.15690/vsp.v24i4.2947
Abstract
Background. Atopic dermatitis (AD) chronic inflammatory skin disease developing associated with genetically determined skin barrier disorders and immune system impairment. In recent years, there is an increase in the proportion of patients with autoimmune diseases (AIDs) among AD cases. Objective. The aim of the study is to examine AIDs incidence among children hospitalized with AD. Methods. The study included patients with moderate or severe AD hospitalized in specialized hospital department from November 2015 to April 2025. AIDs and allergic diseases presence was determined according to medical records. Results. The study included 10,239 patients with AD. Comorbidities (1) were diagnosed in 8103 (79.1%) children, allergic diseases — in 6475 (63.2%). At least one AID was diagnosed in 1,628 children (15.9%; 95% CI 15.3–16.7%). The most common were alopecia areata, celiac disease, and vitiligo. Conclusion. Examination of patients with moderate or severe AD should include evaluation of AIDs symptoms and immunological markers. Common pathogenetic mechanisms allow us to develop united strategy for AD and AIDs early diagnosis and for further follow-up of patients at high-risk group.
Supporting agencies: Not specified.
About the Author
Ekaterina S. Pavlova
National Medical Research Center of Children’s Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared.
References
1. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16. doi: https://doi.org/10.1159/000370220
2. Murashkin NN, Ivanov RA, Fedorov DV, et al. Role of Emollients in Prevention of the Comorbid Allergic Diseases Development in Children with Atopic Dermatitis. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(4):334–339. (In Russ). doi: https://doi.org/10.15690/pf.v17i4.2160
3. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–1122. doi: https://doi.org/10.1016/S0140-6736(15)00149-X
4. Silverberg JI. Associations between atopic dermatitis and other disorders. F1000Res. 2018;7:303. doi: https://doi.org/10.12688/f1000research.12975.1
5. de Lusignan S, Alexander H, Broderick C, et al. Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. J Allergy Clin Immunol. 2022;150(3):709–713. doi: https://doi.org/10.1016/j.jaci.2022.03.030
6. Shin S, Lee JY, Cho H, et al. Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases Is Increasing in Korean Children and Adolescents. Allergy Asthma Immunol Res. 2024;16(3):300–307. doi: https://doi.org/10.4168/aair.2024.16.3.300
7. Oyoshi MK, He R, Kumar L, et al. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol. 2009;102:135–226. doi: https://doi.org/10.1016/S0065-2776(09)01203-6
8. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112(6 Suppl):S128–S139. doi: https://doi.org/10.1016/j.jaci.2003.09.032
9. Malajian D, Guttman-Yassky E. New pathogenic and therapeutic paradigms in atopic dermatitis. Cytokine. 2015;73(2):311–318. doi: https://doi.org/10.1016/j.cyto.2014.11.023
10. Ivert LU, Wahlgren CF, Lindelöf B, et al. Association between atopic dermatitis and autoimmune diseases: a populationbased case-control study. Br J Dermatol. 2021;185(2):335–342. doi: https://doi.org/10.1111/bjd.19624
11. Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis — part I: clinical and pathologic concepts. J Clin Cell Immunol. 2011;2(3):110. doi: https://doi.org/10.4172/2155-9899.1000110
12. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis. J Allergy Clin Immunol. 2011;127(5):1110–1118 doi: https://doi.org/10.1016/j.jaci.2011.01.053
13. Drucker AM, Morra DE, Prieto-Merino D, et al. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis. JAMA Dermatol. 2022;158(5):523–532. doi: https://doi.org/10.1001/jamadermatol.2022.0455
14. Pellerin L, Henry J, Hsu CY. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol. 2013;131(4):1094–1102. doi: https://doi.org/10.1016/j.jaci.2012.12.1566
15. Ahn J, Shin S, Lee GC, et al. Unraveling the link between atopic dermatitis and autoimmune diseases in children: Insights from a large-scale cohort study with 15-year follow-up and shared gene ontology analysis. Allergol Int. 2024;73(2):243–254. doi: https://doi.org/10.1016/j.alit.2023.12.005
16. Lu Z, Zeng N, Cheng Y, et al. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2021;17(1):96. doi: https://doi.org/10.1186/s13223-021-00597-4
17. Wang H, Chen M, Wang T, et al. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis. Front Immunol. 2025;16:1539997. doi: https://doi.org/10.3389/fimmu.2025.1539997
18. Murashkin NN, Namazova-Baranova LS, Ivanov RA, et al. Modern Outlooks on “Atopic March” Secondary Prevention Capabilities in Children with Atopic Dermatitis. Voprosy sovremennoi pediatrii — Current Pediatrics. 2020;19(6):514–519. (In Russ). doi: https://doi.org/10.15690/vsp.v19i6.2142
19. Starshinova AA, Kushnareva EA, Malkova AM, et al. New Coronaviral Infection: Features of Clinical Course, Capabilities of Diagnostics, Treatment and Prevention in Adults and Children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2020;19(2):123–131. (In Russ). doi: https://doi.org/10.15690/vsp.v19i2.2105
20. Kobzeva EA, Levina YG. COVID-19 Morbidity in Children with Bronchial Asthma and Allergies. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2022;19(1):78–81. (In Russ). doi: https://doi.org/10.15690/pf.v19i1.2378.
Review
For citations:
Pavlova E.S. Diseases in Children with Atopic Dermatitis: Retrospective Cross-Sectional Study. Current Pediatrics. 2025;24(4):241-245. (In Russ.) https://doi.org/10.15690/vsp.v24i4.2947
Views:
2
Email this article 
